4//SEC Filing
Schemel Donald Robert 4
Accession 0001437749-19-010783
CIK 0001029125other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 7:29 PM ET
Size
7.2 KB
Accession
0001437749-19-010783
Insider Transaction Report
Form 4
Schemel Donald Robert
Director
Transactions
- Award
Stock Option (right to buy)
2019-05-21+6,800→ 6,800 totalExercise: $2.95Exp: 2029-05-21→ Common Stock (6,800 underlying) - Award
Stock Option (right to buy)
2019-05-21+27,000→ 27,000 totalExercise: $2.95Exp: 2029-05-21→ Common Stock (27,000 underlying)
Footnotes (2)
- [F1]Scheduled to become fully exercisable the day before the annual meeting of stockholders to be held in 2020.
- [F2]Immediately exercisable as to 50% of the shares and scheduled to vest with respect to 25% of the shares on each of May 21, 2020 and May 21, 2021.
Documents
Issuer
Sun BioPharma, Inc.
CIK 0001029125
Entity typeother
Related Parties
1- filerCIK 0001652854
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 7:29 PM ET
- Size
- 7.2 KB